Abstract: The present disclosure provides for methods and compositions for degrading, dissolving or reducing the level of tissue filler implanted in a subject. The pharmaceutical composition contains a thiosulfate, a meta bisulfite, or a combination thereof. Also encompassed by the present disclosure are methods and compositions for treating or preventing a calcification disorder.
Abstract: A composition of matter and method for preparation of a tissue augmentation material. A polysaccharide gel composition is prepared with rheological properties selected for a particular selected application. The method includes preparing a polymeric polysaccharide in a buffer to create a polymer solution or gel suspending properties in the gel and selecting a rheology profile for the desired tissue region.
Abstract: Compounds that function, alone or in combination, as inhibitors of pigmentation for the improvement of mammalian skin are described herein. Specifically, the compounds of the present disclosure, namely chiral, non-racemic compounds, function as pigment formation inhibitors thereof to beautify skin and discourage the production of melanins. One or more products, consumer and otherwise, comprising the chiral, non-racemic compounds are disclosed herein. Methods of employing both the compounds of the present disclosure and the products incorporating the present compounds are also disclosed herein.
Type:
Grant
Filed:
January 4, 2013
Date of Patent:
November 10, 2015
Assignee:
MERZ NORTH AMERICA, INC.
Inventors:
Mitchell A. deLong, Kalla Lynn Kvalnes, Raymond Boissy
Abstract: A composition of matter and method for preparation of a tissue augmentation material. A polysaccharide gel composition is prepared with rheological properties selected for a particular selected application. The method includes preparing a polymeric polysaccharide in a buffer to create a polymer solution or gel suspending properties in the gel and selecting a rheology profile for the desired tissue region.